A health worker prepares to administer Ebola vaccination in the north-western Democratic Republic of the Congo.
Uganda is the testing ground for a new vaccine that could work on more strains of the Ebola virus and other haemorrhagic fevers.
The author, Dr. Steven Hatch, with members of a church in Gbanga, Liberia, in October 2014.
Alarm arose when news spread that Ebola cases had been found in Uganda. Here are the real reasons for concern.
West Africa experienced the worst Ebola outbreak between 2013 and 2016.
The current Ebola outbreak in the DRC is devastating vulnerable communities already affected by displacement and violence.
Health workers in Liberia at the height of the 2014-2016 Ebola outbreak.
Four new Ebola treatments are being tried out in the DRC.
A health worker prepares to administer the experimental Ebola vaccine in north-western DRC.
The new Ebola vaccine is yet to be licensed but evidence shows that it protects against the strain of the virus.
Mali was one of the West African countries affected by the biggest Ebola outbreak ever recorded from 2014 to 2016.
Without the current experimental vaccine the Ebola outbreak in the DRC has the potential to spiral out of control.
Ebola is a dreadful disease and is one of the deadliest infections known to medical science.
Instability in the DRC and Ebola's deadly properties is making it hard to contain the virus.
An experimental Ebola vaccine is being tried to contain the current outbreak in the DRC.
There have been ten Ebola outbreaks recorded from the DRC between 1976 and 2018 from different locations. This implies that the virus is widely spread.
A nurse prepares the Ebola vaccine in Bikoro in the DRC.
Teams administering the Ebola vaccine in the Democratic Republic of Congo are in a race against time to find and help people exposed.
The final trials of the first effective Ebola vaccine show it's safe to use against an outbreak.
A tuberculosis patient holds his medicines received from the government’s tuberculosis center in Rawalpindi, Pakistan.
In the future, consumers in the developed world could choose to purchase products from the companies that do the most to promote global health.
GMOs may very well have filled up that syringe.
Syringe image via www.shutterstock.com
Public health experts enlist the molecular biology tools that create genetically modified organisms – as well as the GMOs themselves – in the fight against emerging infectious diseases.
A health worker injects a woman with an Ebola vaccine during a trial in Monrovia, February 2 2015.
Was the Ebola vaccine 100% effective, or 100% lucky? The good money is on a percentage somewhere in between, but in truth, we will never know.
Ebola has wiped out a third of the world’s gorillas.
There is a side to the Ebola crisis that, perhaps understandably, has received little media attention: the threat it poses to our nearest cousins, the great apes of Africa. At this moment in time Ebola…
What is Ebola?
Despite killing a majority of people it infects, some patients survive the onslaught of Ebola virus. What gives them this resistance, ask Michael Katze, professor of microbiology, and colleagues from the…
Human volunteers for Ebola vaccine.
The world has been warned that the current Ebola epidemic may not end without the use of a vaccine – and no licensed vaccines exist yet. That may soon change, because scientists are making swift progress…